Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction

By sjmartinez • April 30, 2023

Brownell NK, Ziaeian B, Fonarow GC. Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction. JACC Asia. 2022 Apr 19;2(2):154-156. doi: 10.1016/j.jacasi.2022.03.002. PMID: 36339123; PMCID: PMC9627794.

Tags: Asia, Cardiology/Epi, ejection fraction, heart failure, Publications, SGLT2 inhibitor

Bioelectronic block of stellate ganglia mitigates pacing-induced heterogeneous release of catecholamine and neuropeptide Y in the infarcted pig heart

Vrabec T, Bender S, Chan SA, Cha S, Haridas S, Hanna P, Ajijola OA, Shivkumar K, Smith C, Ardell JL. Bioelectronic block of stellate ganglia[...]

Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable

Tobis JM, Carroll JD. Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable? Circulation. 2024 Nov 19;150(21):1669-1670. doi: 10.1161/CIRCULATIONAHA.124.071851. Epub 2024 Nov 18.[...]

Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Abdel Jawad M, Spertus JA, Ikeaba U, Greene SJ, Fonarow GC, Chiswell K, Chan PS. Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With[...]